Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durability of simplified insulin-based combination regimens versus basal-bolus insulin in type 2 diabetes
2019-002977-69Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin lispro (Wockhardt) in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoint: Durability of glycemic control. Started May 2021; status: completed.
02
Drugs
insulin lispro (Wockhardt)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2019-002977-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002977-69.